Your browser doesn't support javascript.
loading
Granulocyte Colony-Stimulating Factor Is Safe and Well Tolerated following Allogeneic Transplantation in Patients with Sickle Cell Disease.
Shah, Niketa C; Bhoopatiraju, Sweta; Abraham, Allistair; Anderson, Eric; Andreansky, Martin; Bhatia, Monica; Chaudhury, Sonali; Cuvelier, Geoff D E; Godder, Kamar; Grimley, Michael; Hale, Gregory; Kamani, Naynesh; Jacobsohn, David; Ngwube, Alexander; Gilman, Andrew L; Skiles, Jodi; Yu, Lolie C; Shenoy, Shalini.
Afiliação
  • Shah NC; Department of Pediatric Hematology Oncology and Bone Marrow transplant, Yale University, New Haven, Connecticut. Electronic address: Niketa.shah@yale.edu.
  • Bhoopatiraju S; St. Louis University, St. Louis, Missouri.
  • Abraham A; Center for Cancer and Blood Disorders, Children's National Hospital, Washington, DC.
  • Anderson E; Division of Hematology Oncology, Rady Children's Hospital, San Diego, California.
  • Andreansky M; Blood and Marrow transplant Program, Baylor College of Medicine, San Antonio, Texas.
  • Bhatia M; Department of Pediatrics, Pediatric Stem Cell Transplant, Irving Medical Center, University of Columbia, New York, New York.
  • Chaudhury S; Division of Pediatric Hematology Oncology and Stem Cell Transplantation, Lurie Children's Hospital, Northwestern University, Chicago, Illinois.
  • Cuvelier GDE; Manitoba Blood and Marrow Transplant Program, Cancer Care Manitoba, Winnipeg, Manitoba, Canada.
  • Godder K; Cancer and Blood Disorders Center, Nicklaus Children's Hospital, Miami, Florida.
  • Grimley M; Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital, Cincinnati, Ohio.
  • Hale G; Cancer and Blood Disorder Institute, All Children's, St. Petersburg, Florida.
  • Kamani N; Center for Cancer and Blood Disorders, Children's National Hospital, Washington, DC.
  • Jacobsohn D; Center for Cancer and Blood Disorders, Children's National Hospital, Washington, DC.
  • Ngwube A; Center for Cancer and Blood Disorder, Phoenix Children's Hospital, Phoenix, Arizona.
  • Gilman AL; ICON, Raleigh, North Carolina.
  • Skiles J; Department of Pediatric Cancer and Blood Disorders, Riley Children's Hospital, Indianapolis, Indiana.
  • Yu LC; Center for Cancer and Blood Disorders, Children's Hospital/LSUHSC, New Orleans, Louisiana.
  • Shenoy S; Division of Pediatric Hematology Oncology, Washington University, St. Louis, Missouri.
Transplant Cell Ther ; 28(3): 174.e1-174.e5, 2022 03.
Article em En | MEDLINE | ID: mdl-34958973
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator Estimulador de Colônias de Granulócitos / Anemia Falciforme Limite: Humans Idioma: En Revista: Transplant Cell Ther Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator Estimulador de Colônias de Granulócitos / Anemia Falciforme Limite: Humans Idioma: En Revista: Transplant Cell Ther Ano de publicação: 2022 Tipo de documento: Article